Peter Stärkel

14.9k total citations · 2 hit papers
153 papers, 6.8k citations indexed

About

Peter Stärkel is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Peter Stärkel has authored 153 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Epidemiology, 59 papers in Hepatology and 55 papers in Molecular Biology. Recurrent topics in Peter Stärkel's work include Liver Disease Diagnosis and Treatment (77 papers), Alcohol Consumption and Health Effects (39 papers) and Gut microbiota and health (32 papers). Peter Stärkel is often cited by papers focused on Liver Disease Diagnosis and Treatment (77 papers), Alcohol Consumption and Health Effects (39 papers) and Gut microbiota and health (32 papers). Peter Stärkel collaborates with scholars based in Belgium, United States and Germany. Peter Stärkel's co-authors include Bernd Schnabl, Philippe de Timary, Sophie Leclercq, Isabelle Leclercq, Nathalie M. Delzenne, Derrick E. Fouts, Bénédicte Delire, Samuel B. Ho, Christine De Saeger and Yves Horsmans and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Peter Stärkel

148 papers receiving 6.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity

2014 711 citations Sophie Leclercq, Sébastien Matamoros et al. Proceedings of the National Academy of Sciences profile →
Enteric dysbiosis associated with a mouse model of alcoholic liver disease

2010 639 citations Derrick E. Fouts, Peter Stärkel et al. Hepatology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Peter Stärkel	3.3k	3.1k	1.8k	1.4k	1.3k	153	6.8k
Pranoti Mandrekar	2.2k 0.7×	3.3k 1.1×	2.5k 1.4×	1.3k 0.9×	576 0.4×	103	7.7k
Donna Catalano	2.8k 0.9×	2.9k 0.9×	2.1k 1.2×	1.1k 0.8×	423 0.3×	81	7.2k
Gabriel Perlemuter	1.6k 0.5×	3.3k 1.0×	946 0.5×	1.9k 1.3×	837 0.6×	112	5.5k
Laura E. Nagy	3.6k 1.1×	4.9k 1.6×	3.4k 1.9×	1.4k 1.0×	1.4k 1.1×	225	10.4k
Lixin Zhu	3.3k 1.0×	2.5k 0.8×	425 0.2×	491 0.4×	1.5k 1.1×	129	6.0k
Ina Bergheim	2.2k 0.7×	3.8k 1.2×	819 0.5×	690 0.5×	2.3k 1.8×	143	6.3k
Michael D. Wheeler	1.4k 0.4×	1.9k 0.6×	1.7k 1.0×	757 0.5×	411 0.3×	77	4.8k
Timon E. Adolph	2.6k 0.8×	2.0k 0.6×	322 0.2×	336 0.2×	1.0k 0.8×	68	5.5k
Yu‐Jui Yvonne Wan	3.1k 0.9×	1.4k 0.4×	519 0.3×	446 0.3×	623 0.5×	184	6.3k
Giovanni Musso	2.6k 0.8×	6.9k 2.2×	1.1k 0.6×	1.8k 1.3×	2.2k 1.7×	87	10.2k

Countries citing papers authored by Peter Stärkel

Since Specialization

Citations

This map shows the geographic impact of Peter Stärkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Stärkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Stärkel more than expected).

Fields of papers citing papers by Peter Stärkel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Stärkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Stärkel. The network helps show where Peter Stärkel may publish in the future.

Co-authorship network of co-authors of Peter Stärkel

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Stärkel. A scholar is included among the top collaborators of Peter Stärkel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Stärkel. Peter Stärkel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cabré, Noemí, Marcos F. Fondevila, Tomoo Yamazaki, et al.. (2025). Activation of intestinal endogenous retroviruses by alcohol exacerbates liver disease. Journal of Clinical Investigation. 135(13). 3 indexed citations

Hu, Yifan, Bernd Schnabl, & Peter Stärkel. (2025). Origin, Function, and Implications of Intestinal and Hepatic Macrophages in the Pathogenesis of Alcohol-Associated Liver Disease. Cells. 14(3). 207–207. 1 indexed citations

Peiffer, Brandon, Yaojie Fu, Yuhong Lin, et al.. (2025). Opposite regulation of intestinal and intrahepatic CD8 ⁺ T cells controls alcohol-associated liver disease progression. Gut. 74(8). 1308–1320. 4 indexed citations

Ahmed, Hany, Sophie Leclercq, Kati Hanhineva, et al.. (2025). Serum Metabolite Profile in Progressive Versus Nonprogressive Alcohol‐Related Liver Disease: A Cross‐Sectional Metabolomics Study. Liver International. 45(6). e70128–e70128. 1 indexed citations

Leclercq, Sophie, Hany Ahmed, Camille Amadieu, et al.. (2024). Blood metabolomic profiling reveals new targets in the management of psychological symptoms associated with severe alcohol use disorder. eLife. 13. 7 indexed citations

Stärkel, Peter, et al.. (2024). Patients with chronic liver diseases are at risk for diabetes even before development of cirrhosis. Clinics and Research in Hepatology and Gastroenterology. 48(8). 102428–102428.

Hsu, Cynthia L., Sonja Lang, Münevver Demir, et al.. (2023). Any alcohol use in NAFLD patients is associated with significant changes to the intestinal virome. Hepatology. 77(6). 2073–2083. 18 indexed citations

Zeng, Su-Ling, Phillipp Hartmann, Minji Park, et al.. (2023). Malassezia restricta promotes alcohol-induced liver injury. Hepatology Communications. 7(2). e0029–e0029. 16 indexed citations

Maccioni, Luca, Yves Horsmans, Isabelle Leclercq, Bernd Schnabl, & Peter Stärkel. (2023). Serum keratin 18‐M65 levels detect progressive forms of alcohol‐associated liver disease in early noncirrhotic stages. Alcohol Clinical and Experimental Research. 47(6). 1079–1087. 6 indexed citations

10.

Maccioni, Luca, Sophie Leclercq, Géraldine Laloux, et al.. (2023). Toll-like receptor 2 activation in monocytes contributes to systemic inflammation and alcohol-associated liver disease in humans. Hepatology Communications. 7(5). 7 indexed citations

11.

Gao, Bei, Yixin Zhu, Weishou Shen, Peter Stärkel, & Bernd Schnabl. (2022). Correlation between Serum Steroid Hormones and Gut Microbiota in Patients with Alcohol-Associated Liver Disease. Metabolites. 12(11). 1107–1107. 2 indexed citations

12.

Gao, Bei, Yixin Zhu, Nan Gao, et al.. (2021). Integrative Analysis of Metabolome and Microbiome in Patients with Progressive Alcohol-Associated Liver Disease. Metabolites. 11(11). 766–766. 3 indexed citations

13.

Demir, Münevver, Sonja Lang, Phillipp Hartmann, et al.. (2021). The fecal mycobiome in non-alcoholic fatty liver disease. Journal of Hepatology. 76(4). 788–799. 131 indexed citations

14.

Zhou, Rongrong, Cristina Llorente, Jinling Cao, et al.. (2020). Deficiency of Intestinal α1‐2‐Fucosylation Exacerbates Ethanol‐Induced Liver Disease in Mice. Alcoholism Clinical and Experimental Research. 44(9). 1842–1851. 16 indexed citations

15.

Goeminne, Léonie, Chris Verhofstede, Hector Rodriguez‐Villalobos, et al.. (2019). Comparison of Sanger sequencing for hepatitis C virus genotyping with a commercial line probe assay in a tertiary hospital. BMC Infectious Diseases. 19(1). 738–738. 4 indexed citations

16.

Ciccarelli, Olga, Arthur Colson, Christine De Saeger, et al.. (2018). Tumoral response and tumoral phenotypic changes in a rat model of diethylnitrosamine-induced hepatocellular carcinoma after salirasib and sorafenib administration. OncoTargets and Therapy. Volume 11. 7143–7153. 6 indexed citations

17.

Delire, Bénédicte, Peter Stärkel, & Isabelle Leclercq. (2015). Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development. Journal of Clinical and Translational Hepatology. 3(1). 53–66. 120 indexed citations

18.

Leclercq, Sophie, Sébastien Matamoros, Patrice D. Cani, et al.. (2014). Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proceedings of the National Academy of Sciences. 111(42). E4485–93. 711 indexed citations breakdown →

19.

Damme, Pierre Van, Wim Laleman, Peter Stärkel, et al.. (2014). Hepatitis C epidemiology in Belgium.. PubMed. 77(2). 277–9. 5 indexed citations

20.

Orlent, Hans, Hendrik Reynaert, Stefan Bourgeois, et al.. (2011). IL28B polymorphism and the control of hepatitis C virus infection: ready for clinical use?. PubMed. 74(2). 317–22. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact